Back to Search Start Over

Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic Review

Authors :
David C. Fajgenbaum
Johnson S. Khor
Alexander Gorzewski
Mark-Avery Tamakloe
Victoria Powers
Joseph J. Kakkis
Mileva Repasky
Anne Taylor
Alexander Beschloss
Laura Hernandez-Miyares
Beatrice Go
Vivek Nimgaonkar
Madison S. McCarthy
Casey J. Kim
Ruth-Anne Langan Pai
Sarah Frankl
Philip Angelides
Joanna Jiang
Rozena Rasheed
Erin Napier
Duncan Mackay
Sheila K. Pierson
Source :
Infectious Diseases and Therapy, Vol 9, Iss 3, Pp 435-449 (2020)
Publication Year :
2020
Publisher :
Adis, Springer Healthcare, 2020.

Abstract

Abstract The emergence of SARS-CoV-2/2019 novel coronavirus (COVID-19) has created a global pandemic with no approved treatments or vaccines. Many treatments have already been administered to COVID-19 patients but have not been systematically evaluated. We performed a systematic literature review to identify all treatments reported to be administered to COVID-19 patients and to assess time to clinically meaningful response for treatments with sufficient data. We searched PubMed, BioRxiv, MedRxiv, and ChinaXiv for articles reporting treatments for COVID-19 patients published between 1 December 2019 and 27 March 2020. Data were analyzed descriptively. Of the 2706 articles identified, 155 studies met the inclusion criteria, comprising 9152 patients. The cohort was 45.4% female and 98.3% hospitalized, and mean (SD) age was 44.4 years (SD 21.0). The most frequently administered drug classes were antivirals, antibiotics, and corticosteroids, and of the 115 reported drugs, the most frequently administered was combination lopinavir/ritonavir, which was associated with a time to clinically meaningful response (complete symptom resolution or hospital discharge) of 11.7 (1.09) days. There were insufficient data to compare across treatments. Many treatments have been administered to the first 9152 reported cases of COVID-19. These data serve as the basis for an open-source registry of all reported treatments given to COVID-19 patients at www.CDCN.org/CORONA . Further work is needed to prioritize drugs for investigation in well-controlled clinical trials and treatment protocols.

Details

Language :
English
ISSN :
21938229 and 21936382
Volume :
9
Issue :
3
Database :
Directory of Open Access Journals
Journal :
Infectious Diseases and Therapy
Publication Type :
Academic Journal
Accession number :
edsdoj.70d88cce1190417b81858fddcc545388
Document Type :
article
Full Text :
https://doi.org/10.1007/s40121-020-00303-8